Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time
Open Access
- 5 July 2013
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 166
Abstract
Background: The purpose of this study was to analyze the efficacy and tolerability of palliative radiotherapy (RT) in patients with a poor performance status (PS) and to evaluate the relationship between the palliative effect and survival time. Methods: One hundred and thirty-three patients with a poor PS (Eastern Cooperative Oncology Group 3 or 4) were treated with palliative RT using the three-dimensional conformal technique and retrospectively analyzed. Each patient's primary symptom treated with palliative RT as the major cause of the poor PS was evaluated using the second item of the Support Team Assessment Schedule (STAS) at the start and one week after the completion of palliative RT. Results: One hundred and fourteen (86%) of the 133 patients completed the planned palliative radiation dose. Grade 3 acute toxicity was observed in two patients (2%) and Grade 2 acute toxicity was observed in 10 patients (9%). No Grade 2 or higher late toxicities were observed, except for Grade 3 radiation pneumonitis in one patient. Improvement in the STAS scores between pre- and post-palliative RT was recorded in 76 (61%) of the 125 patients with available scores of STAS. A significant improvement in the mean STAS score between pre- and post-palliative RT was recognized (p < 0.0001). Improvement in the STAS score was found to be the most statistically significant prognostic factor for overall survival after palliative RT in both the multivariate and univariate analyses. The median overall survival time in the patients with an improvement in the STAS score was 6.4 months, while that in the patients without improvement was 2.4 months (p < 0.0005). Conclusions: Palliative RT in patients with a poor PS provides symptomatic benefits in more than half of patients without inducing severe toxicities. The palliative effect is strongly correlated with prolongation of the survival time and may contribute to improving the remaining survival time in patients with metastatic/advanced cancer with a poor PS.Keywords
This publication has 28 references indexed in Scilit:
- Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factorsClinical & Experimental Metastasis, 2013
- Survey on Use of Palliative Radiotherapy in Hospice CareJournal of Clinical Oncology, 2004
- Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinicInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Baseline quality of life predicts survival in patients with advanced colorectal cancerEuropean Journal of Cancer, 2002
- Changes in performance status of elderly patients after radiotherapy.2001
- Factors Affecting the Use of Palliative Radiotherapy in OntarioJournal of Clinical Oncology, 2001
- The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapyRadiotherapy and Oncology, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Measuring patient outcomes in palliative care: a reliability and validity study of the Support Team Assessment SchedulePalliative Medicine, 2000